Cargando…
The potential of patient-derived organoids in precision medicine of biliary tract cancer
Chemotherapy resistance in biliary tract cancer (BTC) presents a major clinical hurdle. Ren et al.(1) developed and characterized an extensive collection of BTC patient-derived organoid (PDO) models, enabling advanced investigation of chemotherapy response prediction.
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10694744/ https://www.ncbi.nlm.nih.gov/pubmed/37992681 http://dx.doi.org/10.1016/j.xcrm.2023.101294 |